Join to View Full Profile
UF Health ShandsGainesville, FL 32608
Dr. Chatzkel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2016
Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Certifications & Licensure
FL State Medical License 2016 - 2026
MO State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.Thomas J George, Ji-Hyun Lee, David L DeRemer, Peter J Hosein, Steven Staal
JCO Precision Oncology. 2024-12-01 - Cecal Metastasis of Clear Cell Renal Cell Carcinoma After Previous Nephrectomy.Rick Y Lin, Steve Shen, Patrick L Donabedian, Calvin Kiani, Jesse L Kresak
ACG Case Reports Journal. 2024-05-01 - Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic.Jonathan Chatzkel, Mayer Fishman, Brian Ramnaraign, Padraic O'Malley, Guru P Sonpavde
Research and Reports in Urology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
